David Katz

|RSS

David Katz is the president and chief investment officer of Matrix Asset Advisors, which he co-founded in 1986. Prior to co-founding Matrix, he worked at Management Asset Corp. in the research and portfolio management areas. At Matrix, Katz chairs the Investment Policy Committee.Expand

Katz is a CFA charterholder who appears frequently as a guest on CNBC, Bloomberg Television and Radio and WCBS-AM in New York. He graduated summa cum laude from Union College with a Bachelor of Arts degree in economics. He received a Master of Business Administration degree, with a concentration in finance, from New York University Graduate School of Business in 1987, graduating with distinction. His numerous works on value investing earned him various awards and distinctions at the undergraduate and graduate levels.Collapse

By

David Katz

 | Sep 30, 2014 | 10:30 AM EDT

A low-risk way to participate in the technology sector's growth.

By

David Katz

 | Sep 29, 2014 | 8:24 AM EDT
We have been pretty vocal, along with Herb Greenberg, about TIBCO Software as we thought there was a good likelihood that the Goldman Sachs'...
By

David Katz

 | Sep 26, 2014 | 10:30 AM EDT

Innovative investors could shake up Kellogg and General Mills.

 

By

David Katz

 | Sep 26, 2014 | 8:51 AM EDT
The market got beaten up pretty good yesterday, and the "Down 264 on the Dow Jones Industrial Average" is a pretty scary headline. With the...
By

David Katz

 | Sep 23, 2014 | 1:30 PM EDT

Many sector stocks have a compelling reward vs. risk profile.

By

David Katz

 | Sep 19, 2014 | 8:00 AM EDT

Screen shows nothing exciting among the laggards.

By

David Katz

 | Sep 19, 2014 | 7:05 AM EDT
McDonalds raised its dividend by 4 cents last night to 85 cents, which brings the stock's current yield up to 3.64%. This raise is in line with the 4...
By

David Katz

 | Sep 16, 2014 | 1:30 PM EDT

Take advantage of the swoon in the energy sector to stock up on some of our favorite names.

By

David Katz

 | Sep 12, 2014 | 11:44 AM EDT

 Hepatitis C therapies are the pacesetters.

By

David Katz

 | Sep 9, 2014 | 8:00 AM EDT

Three companies offer good value amid growth. 

Cramer:  

Can really run on this new phase two data--I would buy it right here ...

The two volatility themes for the week are the NFP number and democracy protests in China....
We may see some weird, late in the day, moves as the third quarter comes to a close. Thinl...
Market opens slightly down to begin trading for the last day of the quarter. Asia is in fo...

BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.